Hangzhou Dian Zhengjian Testing Technology Co., Ltd. announced that it will receive CNY 40,000,000 in a round of equity funding from existing investor Zhejiang DIAN Diagnostics Co., Ltd. on April 12, 2016. Post the closing of the transaction; the investor will maintain its stake of 100% in the company's issued and outstanding share capital for a total amount of CNY 50,000,000. The transaction has been approved at the 52nd session of the 2nd directorate of the investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.36 CNY | -0.83% | -3.88% | -39.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.69% | 1.25B | |
-18.11% | 8.02B | |
+33.79% | 3.51B | |
-29.02% | 2.97B | |
-7.71% | 2.48B | |
-14.30% | 2.23B | |
-16.38% | 1.76B | |
-22.17% | 1.44B | |
-11.20% | 1.11B | |
+3.66% | 1.07B |
- Stock Market
- Equities
- 300244 Stock
- News Dian Diagnostics Group Co.,Ltd.
- Hangzhou Dian Zhengjian Testing Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang DIAN Diagnostics Co., Ltd.